Fetal effects during cyclophosphamide and irradiation therapy.
about
Anti-inflammatory and immunosuppressive drugs and reproductionApparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype?Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease.Breast cancer during pregnancy: cases and review of treatment and prognosis.Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway?Maternal aldehyde elimination during pregnancy preserves the fetal genomeProblems with immunosuppressive agents in renal diseaseWegener's granulomatosis in pregnancy: a case report and review of the medical literatureEnvironmental teratogens.Treatment of pregnancy-associated breast cancer.Cancer chemotherapeutic agents as human teratogens.Management and controversies of classical Hodgkin lymphoma in pregnancy.Potential human developmental toxicants and the role of animal testing in their identification and characterization.Cyclophosphamide teratogenesis: a review.Multiple agent chemotherapy including bleomycin of non-Hodgkin's lymphoma during pregnancy.Normal infant after treatment of acute myeloid leukaemia in pregnancy with daunorubicin.The management of urological malignancies during pregnancy.Effects of immunosuppressive drugs during pregnancy.Complications of cyclophosphamide therapy.Pregnancy outcome of patients treated for Hodgkin's disease: a controlled study.Combined chemotherapy and teratogenicity.Factors associated with fetal losses in severe systemic lupus erythematosus.Differentiation of cyclophosphamide-treated hamster secondary palate: ultrastructural and biochemical observations.'Pulsed' immunosuppressive therapy in the treatment of immunologically induced corneal and scleral disease.Normal infant after combination chemotherapy including teniposide for Burkitt's lymphoma in pregnancy.Klippel-Feil syndrome in a boy exposed inadvertently to cyclophosphamide during pregnancy: a case report.
P2860
Q28218219-BDB301A8-2280-4F51-A983-F6C19D35B625Q28372707-D91DEF5C-271E-4D87-96E9-79F871AE6BCBQ33648618-1748C6D2-DE58-482D-8BA5-334B1E246010Q33958777-8D3BF768-41CE-4D9A-B854-953448CA2BDFQ34228830-21F0789C-6414-43B7-A4C7-E3C951E206D6Q34244123-C1EE49D1-BE9E-4557-AAC8-DDA18A28774AQ34302895-AA5CD9D3-B252-4B5D-B474-C6C2D9E817DDQ34534725-45A4A59C-37FE-47F7-AC16-D17C87250F88Q35662122-6D62B100-54DF-44A7-995A-84BF232EBD56Q37575523-98108A66-74B3-42A1-BCB9-19B5285B229CQ38031187-A2C3E939-3E2D-486F-A266-5068D4B55B5DQ38356460-03E229F8-6A72-4581-9083-2A5014CAEBD1Q38625359-4388DACF-3E8F-4BCC-B8EA-7B835F81F647Q39360828-6B2117CB-102A-4E02-AD80-37C527119AEDQ39465529-0EF51429-4960-46DE-8E35-2108661B9B6CQ40575013-F6CE8EA9-1FFA-40DE-BAE3-E11E17386F65Q40931482-229BF981-FE36-4528-8D21-796F45F33F61Q41145652-D4311665-3F54-4A26-A206-2B6C706E3298Q41378713-F428B76C-D366-4200-9F13-0BE14E3D6A0BQ41387416-289FE6AD-4570-4572-A1ED-F02479E13EBDQ41920240-97D13BC9-87F0-4431-A2AE-E90ECD14C421Q41931078-1B9DAAAD-6C0E-454B-9173-DD3628CF637DQ42483433-B23098DE-139D-446A-810C-09480405C074Q44395053-56303F1E-57E9-40C0-A704-347724DE245FQ47614009-33A35D2A-DD35-46B4-9C56-67F3CE645D62Q51799336-B7B84D3A-CBEC-40BB-900D-60F4280B6B2A
P2860
Fetal effects during cyclophosphamide and irradiation therapy.
description
1971 nî lūn-bûn
@nan
1971年の論文
@ja
1971年論文
@yue
1971年論文
@zh-hant
1971年論文
@zh-hk
1971年論文
@zh-mo
1971年論文
@zh-tw
1971年论文
@wuu
1971年论文
@zh
1971年论文
@zh-cn
name
Fetal effects during cyclophosphamide and irradiation therapy.
@en
Fetal effects during cyclophosphamide and irradiation therapy.
@nl
type
label
Fetal effects during cyclophosphamide and irradiation therapy.
@en
Fetal effects during cyclophosphamide and irradiation therapy.
@nl
prefLabel
Fetal effects during cyclophosphamide and irradiation therapy.
@en
Fetal effects during cyclophosphamide and irradiation therapy.
@nl
P2093
P1476
Fetal effects during cyclophosphamide and irradiation therapy.
@en
P2093
P356
10.7326/0003-4819-74-1-87
P407
P577
1971-01-01T00:00:00Z